BioSight Ltd, a pharmaceutical company developing innovative therapeutics for hematological malignancies and disorders, announced today the raising of a $19M Series C financing. The investment was led by Israel Biotech Fund, joined by SBI JI Innovation Fund, Arkin Bio Ventures and additional new and existing investors.
Biosight Raises $19M in Series C Funding led by Israel Biotech Fund
![BioSight logo](https://ibf.fund/wp-content/uploads/2020/04/biosight-featured-image.png)